About this trial
The goal of this observational study is to collect short video and sound recordings of people with cancer to create a secure database that can be used in future research to develop an artificial intelligence (AI) tool for pain assessment. The main aim is to build a large, high-quality collection of audiovisual data showing how people with cancer express themselves when they do and do not have pain.
Participants will include adults with cancer who are admitted to the oncology ward for pain treatment and a control group admitted for chemotherapy who have no pain. After giving consent, participants will:
* Be recorded on video (from the shoulders up) for up to 60 seconds while reading a short sentence and describing their pain or daily experience. * Complete a short questionnaire about their mood and pain expression. * Allow researchers to collect some information from their medical record, such as their pain score, medications, and cancer type.
These recordings will be securely stored and used to create a database for future AI research. No medical tests, new treatments, or extra hospital visits are involved. This study will provide the foundation for developing future AI-based tools that could support doctors and patients in monitoring and managing pain more accurately and easily.
Eligibility criteria
Qualifiers
Adult patients (≥18 years)
Diagnosed with cancer, active
Able to communicate verbally in Dutch or English
Able to provide written informed consent.
Disqualifiers
Cognitive, physical, or medical limitations that prevent participation in the audiovisual recording sessions or affect facial expressions or voice (e.g. facial paralysis, tracheostomy, severe speech impairment).
Critical illness or end-of-life care where participation would impose an additional burden.
Experiencing pain not associated with cancer
Infectious isolation precautions that prevent safe data collection
Trial design
Treatments tested in this trial
- Audiovisual and questionnaire-based data collection (once)
- Audiovisual and questionnaire-based data collection (consecutive)
Treatment groups
Sponsors and collaborators
Dr. Mark Mulder
Lead sponsor
Erasmus Medical Center
Sponsor institution
Delft University of Technology
Collaborator